Cell
Volume 70, Issue 6, 18 September 1992, Pages 901-910
Journal home page for Cell

Article
Dominant negative MYC blocks transformation by ABL oncogenes

https://doi.org/10.1016/0092-8674(92)90241-4Get rights and content

Abstract

A link between ABL oncogenes and MYC is suggested by the transformation synergy that is observed when MYC is expressed at high levels. Dominant negative MYC proteins were overexpressed in fibroblasts to determine if MYC complements ABL oncogene transformation or is essential for this process. Transformation by both v-abl and BCR-ABL oncogenes was reduced 5- to 10-fold, whereas transformation by the serine/threonine kinase oncogene v-mos was unaffected. Using a retrovirus construct modified to express BCR-ABL and MYC genes simultaneously, we show that dominant negative MYC suppressed transformation of primary mouse bone marrow pre-B cells by BCR-ABL. These observations demonstrate that c-MYC is essential for transformation and help define the pathway by which these proteins cause transformation.

References (43)

  • T.K. Blackwell et al.

    Sequence-specific DNA binding by the c-Myc protein

    Science

    (1990)
  • E.M. Blackwood et al.

    Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc

    Science

    (1991)
  • J.L. Cleveland et al.

    Tyrosine kinases oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl

    Mol. Cell. Biol.

    (1989)
  • C.V. Dang et al.

    Involvement of the “leucine zipper” region in the oligomerization and transforming activity of human c-myc protein

    Nature

    (1989)
  • M. Dean et al.

    Role of c-myc in the abrogation of IL-3 dependence of myeloid FDC-P1 cells

    Oncogene Res.

    (1987)
  • J.E. DeClue et al.

    Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus

    Mol. Cell. Biol.

    (1991)
  • G.I. Evan et al.

    Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

    Mol. Cell. Biol.

    (1985)
  • M. Fujii et al.

    Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos

    Mol. Cell. Biol.

    (1989)
  • T.D. Halazonetis et al.

    Determination of the c-MYC DNA-binding site

  • P. Jackson et al.

    N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl

    EMBO J.

    (1989)
  • G.J. Kato et al.

    An amino-terminal c-Myc domain required for neoplastic transformation activates transcription

    Mol. Cell. Biol.

    (1990)
  • Cited by (380)

    • CXCR2, a novel target to overcome tyrosine kinase inhibitor resistance in chronic myelogenous leukemia cells

      2021, Biochemical Pharmacology
      Citation Excerpt :

      c-Myc is related to BCR-ABL transformation and plays a crucial role in CML progression from the chronic phase to blast crisis. Inhibiting c-Myc induces reduced BCR-ABL activity [53,54] because c-Myc binds to the BCR promoter and directly regulates BCR activity [45]. These reports indicate that IL-8 secretion is associated with BCR-ABL activity.

    View all citing articles on Scopus
    View full text